切伦科夫成像用于放疗实时验证的综述
本文评估将切伦科夫成像整合进放疗实践的效用,关注其提升治疗精度、患者安全与临床决策的价值。方法采用BeamSite与DoseRT两套商用系统,配合Varian与Elekta直线加速器,在放疗中实时成像并与辐射脉冲同步采集切伦科夫光,治疗后分析图像评估治疗准确性与剂量分布。结果显示该技术可即时可视化剂量分布、实时发现偏差并确认关注区域无照射,在乳腺癌等复杂场景中尤为有益,且未显著增加流程时间。
要点
- 切伦科夫成像可实时可视化剂量分布并即时发现治疗偏差
- 在乳腺癌治疗与体位困难病例中尤为有益
- 不显著增加临床流程时间,可补充传统验证方法
核心结论
- 切伦科夫成像在提供实时可视化治疗反馈方面显示出显著前景,可补充传统验证方法并有望减少治疗差错、改善患者结局。
- 作者认为应考虑更广泛的临床采纳,但图像处理与相机定位仍需进一步改进以提升效果。
研究设计与样本
- 采用两套商用切伦科夫成像系统BeamSite与DoseRT,整合Varian与Elekta直线加速器。
- 在多种放疗过程中实时成像,用与辐射脉冲同步的时间门控相机采集切伦科夫光,治疗后分析图像评估治疗准确性、剂量分布与计划偏差。
主要发现
- 切伦科夫成像持续提供高质量图像,可即时可视化辐射剂量分布并实时检测偏差。
- 结果按五个主题呈现:质量与患者安全验证、乳腺治疗应用、治疗验证的剂量可视化、关注区域负剂量验证、具临床影响的观察。
- 该技术在乳腺癌治疗等复杂场景及患者体位困难的病例中特别有益,可促成即时治疗调整并提升患者安全,且未显著增加临床流程时间。
临床怎么用
- 可将切伦科夫成像用于放疗实时质量与安全验证,即时发现并纠正剂量偏差。
- 在乳腺癌治疗及体位困难病例中可优先考虑该技术以辅助治疗调整。
- 作为传统验证方法的补充手段,提供连续监测而不显著延长流程时间。
局限性
- 图像处理与相机定位仍需进一步改进以增强该技术的有效性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: This paper aimed to evaluate the integration of Cherenkov imaging into radiation therapy practices, focusing on its utility in enhancing treatment precision, patient safety, and clinical decision-making. The research highlights its application in quality and safety verification, breast treatment, and dose visualization, confirming the absence of radiation in unintended areas and its broader clinical impact. METHODS AND MATERIALS: We employed 2 commercially available Cherenkov imaging systems, BeamSite and DoseRT, integrated with Varian and Elekta linear accelerators. The methodology involved real-time imaging during radiation therapy sessions for various treatments, capturing Cherenkov light with time-gated cameras synchronized with radiation pulses. Posttreatment, images were analyzed to assess treatment accuracy, dose distribution, and any deviations from the intended plan. RESULTS: Cherenkov imaging consistently provided high-quality images that allowed immediate visualization of the radiation dose distribution, detection of deviations in real time, and ensured no radiation was delivered to unintended areas. The results are presented, focusing on 5 main topics: quality and patient safety verification; breast treatment applications; dose visualization for treatment verification; verification of a negative dose in areas of concern; and observations with clinical impact. It was particularly beneficial in complex scenarios like breast cancer treatments and in cases where patient positioning was challenging. The technology facilitated immediate treatment adjustments, improved patient safety, and offered insights into treatment response without adding significant time to the clinical workflow. CONCLUSIONS: Cherenkov imaging has shown substantial promise in enhancing radiation therapy by providing real-time, visual feedback on treatment delivery. It complements traditional verification methods by offering continuous monitoring, which can lead to fewer treatment errors and better patient outcomes. The findings suggest that Cherenkov imaging should be considered for broader clinical adoption to elevate the standard of care in radiation oncology, although further refinement of image processing and camera positioning could enhance its effectiveness.
引用
- Robinson A, Tallhamer M, Stieler F, et al. A Review of Cherenkov Imaging for Real-Time Verification in Radiation Therapy. Pract Radiat Oncol. 2025. PMID: 41197798. doi:10.1016/j.prro.2025.09.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。